SCHEMBL6479175

SCHEMBL6479175

[CH2]c1c(CC)[nH]c2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.46
ALDH1A1 P00352 2/20 0.44
GPR3 P46089 1/20 0.44
HSD17B10 Q99714 1/20 0.44
HTT P42858 2/20 0.43
CHRNB2 P17787 1/20 0.42
CHRNA7 P36544 1/20 0.42
CHRNA4 P43681 1/20 0.42
AHR P35869 2/20 0.41
CYP1A2 P05177 1/20 0.40
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
ATM Q13315 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP2D6 P10635 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6882102 0.79 HTT (0.55) KIF11ALDH1A1GPR3HSD17B10HTT
Water SCHEMBL11540986 0.78 HTT (0.53) KIF11ALDH1A1GPR3HSD17B10HTT
SCHEMBL1917841 0.78 AHR (0.57) KIF11ALDH1A1GPR3HSD17B10HTT
SCHEMBL16572864 0.77 KIF11 (0.43) KIF11ALDH1A1GPR3HSD17B10HTT
SCHEMBL16973815 0.76 ALDH1A1 (0.46) KIF11ALDH1A1GPR3HSD17B10HTT
SCHEMBL18015851 0.76 KIF11 (0.46) KIF11ALDH1A1GPR3HSD17B10HTT
SCHEMBL11382073 0.76 KIF11 (0.46) KIF11ALDH1A1GPR3HSD17B10HTT
SCHEMBL13437643 0.76 KIF11 (0.46) KIF11ALDH1A1GPR3HSD17B10HTT
SCHEMBL9012812 0.76 KDM4E (0.51) KIF11ALDH1A1GPR3HSD17B10HTT
SCHEMBL10644926 0.76 KIF11 (0.46) KIF11ALDH1A1GPR3HSD17B10HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962938-B2 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-6720329-B2 ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA 2004-04-13 US disclosed